Autoantibodies to IA-2 in insulin-dependent diabetes mellitus: Measurements with a new immunoprecipitation assay
- 20 January 2000
- journal article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 291 (1), 53-66
- https://doi.org/10.1016/s0009-8981(99)00199-0
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetesDiabetes, 1997
- Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody testDiabetes, 1997
- Antibodies to the Tyrosine Phosphatase-like Protein IA-2 are highly associated with IDDM, but not with Autoimmune Endocrine Diseases or Stiff Man SyndromeAutoimmunity, 1997
- Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylaseExperimental and Clinical Endocrinology & Diabetes, 1997
- Autoantibody against IA-2 Improves the Test Sensitivity for Insulin-Dependent Diabetes Mellitus in Japanese Patients of Child Onset.Endocrine Journal, 1997
- IA-2 and IA-2β are Major Autoantigens in IDDM and the Precursors of the 40 kDa and 37 kDa Tryptic FragmentsJournal of Autoimmunity, 1996
- Islet cell autoantigens in type 1 diabetesEuropean Journal of Clinical Investigation, 1996
- Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase.JCI Insight, 1993
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970